Source: FinanzNachrichten

Doc.ai: doc.ai and UCB Biopharma Team Up to Develop Breakthrough Artificial Intelligence Models to Advance Care

New digital health trial will leverage state-of-the-art tech to detect and predict myasthenia gravis symptom patterns and flares doc.ai, an enterprise AI platform accelerating digital transformati...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Sam De Brouwer's photo - Co-Founder & CEO of Doc.ai

Co-Founder & CEO

Sam De Brouwer

CEO Approval Rating

90/100

Read more